BUZZ-Allergan Inc: In talks with Actavis - Bloomberg
** Botox-maker's shares up 1.06 pct at $197.43; Actavis Plc shares down 1.16 pct at $240.79
** Actavis in talks to buy Allergan for at least $60 bln, Bloomberg reports, citing sources
** Deal could culminate this month, Bloomberg reports (bloom.bg/1ubCVL6)
** Allergan, which has a market value of about $58 billion, is currently fending off a hostile takeover from Canadian drugmaker Valeant Pharmaceuticals Inc and activist investor William Ackman's Pershing Square Capital Management
** Up to Tuesday's close, Allergan's shares up about 38 pct since April 21, when Valeant first made its bid
** U.S.-listed shares of Valeant marginally up at $130.21
© Thomson Reuters 2017 All rights reserved.